(Q45743874)

15 December 2017

title

Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays (English)

1 reference

15 December 2017

1 reference

1 reference

Jean-Michel Pawlotsky

1

1 reference

15 December 2017

author name string

Bastie A

2

1 reference

15 December 2017

Hézode C

3

1 reference

15 December 2017

Lonjon I

4

1 reference

15 December 2017

Darthuy F

5

1 reference

15 December 2017

Rémiré J

6

1 reference

15 December 2017

Dhumeaux D

7

1 reference

15 December 2017

publication date

1 March 2000

1 reference

15 December 2017

Journal of Virological Methods

published in

1 reference

15 December 2017

volume

85

1 reference

15 December 2017

issue

1-2

1 reference

15 December 2017

page(s)

11-21

1 reference

15 December 2017

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

A novel method for real time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Chronic type B hepatitis and the "healthy" HBsAg carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Quantitative detection of hepatitis B virus DNA with a new PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Molecular virology and pathogenesis of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Measuring hepatitis C viremia in clinical samples: can we trust the assays?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

What technique should be used for routine detection and quantification of HBV DNA in clinical samples?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Clinical aspects of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Comparison of a quantitative standardized HBV-DNA assay and a classical spot hybridization test in chronic active hepatitis B patients undergoing antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900149-4

7 January 2021

10.1016/S0166-0934(99)00149-4

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017